Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $53.9 million.

  • Upstream Bio's Shares Outstanding (Weighted Average) rose 168392.92% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 168392.92%. This contributed to the annual value of $13.7 million for FY2024, which is 36321.79% up from last year.
  • Latest data reveals that Upstream Bio reported Shares Outstanding (Weighted Average) of $53.9 million as of Q3 2025, which was up 168392.92% from $53.8 million recorded in Q2 2025.
  • Upstream Bio's 5-year Shares Outstanding (Weighted Average) high stood at $53.9 million for Q3 2025, and its period low was $3.0 million during Q4 2023.
  • For the 3-year period, Upstream Bio's Shares Outstanding (Weighted Average) averaged around $21.1 million, with its median value being $3.0 million (2024).
  • In the last 5 years, Upstream Bio's Shares Outstanding (Weighted Average) surged by 217.76% in 2024 and then skyrocketed by 168987.84% in 2025.
  • Upstream Bio's Shares Outstanding (Weighted Average) (Quarter) stood at $3.0 million in 2023, then surged by 363.22% to $13.7 million in 2024, then soared by 294.17% to $53.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $53.9 million for Q3 2025, versus $53.8 million for Q2 2025 and $53.6 million for Q1 2025.